- Report
- February 2024
- 200 Pages
Global
From €1739EUR$1,900USD£1,478GBP
- Report
- August 2020
- 65 Pages
Global
From €4531EUR$4,950USD£3,851GBP
- Report
- April 2024
- 137 Pages
Global
From €2745EUR$2,999USD£2,333GBP
- Report
- December 2023
- 158 Pages
Global
From €2289EUR$2,500USD£1,945GBP
- Report
- April 2023
- 111 Pages
Global
From €4348EUR$4,750USD£3,695GBP
- Report
- January 2025
- 82 Pages
Vietnam
From €3204EUR$3,500USD£2,723GBP
- Report
- December 2024
- 87 Pages
Spain
From €3204EUR$3,500USD£2,723GBP
- Report
- October 2024
- 82 Pages
India
From €3204EUR$3,500USD£2,723GBP
From €3204EUR$3,500USD£2,723GBP
- Report
- August 2024
- 80 Pages
Spain
From €3204EUR$3,500USD£2,723GBP
- Report
- August 2024
- 82 Pages
Japan
From €3204EUR$3,500USD£2,723GBP
- Report
- August 2024
- 80 Pages
Saudi Arabia
From €3204EUR$3,500USD£2,723GBP
- Report
- July 2024
- 80 Pages
Japan
From €3204EUR$3,500USD£2,723GBP
- Report
- June 2024
- 85 Pages
India
From €3204EUR$3,500USD£2,723GBP
- Report
- April 2024
- 180 Pages
Global
From €4119EUR$4,500USD£3,501GBP
- Report
- April 2024
- 185 Pages
Global
From €4119EUR$4,500USD£3,501GBP
- Report
- February 2024
- 182 Pages
Global
From €4119EUR$4,500USD£3,501GBP
- Report
- February 2024
- 170 Pages
Global
From €4119EUR$4,500USD£3,501GBP
- Report
- November 2023
- 77 Pages
Germany
From €3204EUR$3,500USD£2,723GBP
- Report
- November 2023
- 70 Pages
France
From €3204EUR$3,500USD£2,723GBP

Macular Degeneration is a condition that affects the central part of the retina, known as the macula, which is responsible for sharp, central vision. It is the leading cause of vision loss in people over the age of 50. Optical treatments for Macular Degeneration include laser photocoagulation, photodynamic therapy, and anti-VEGF injections. Laser photocoagulation is used to reduce the risk of further vision loss by sealing off leaking blood vessels in the macula. Photodynamic therapy is used to reduce the growth of abnormal blood vessels in the macula. Anti-VEGF injections are used to reduce the growth of abnormal blood vessels and improve vision.
Companies in the Macular Degeneration market include Novartis, Regeneron, Allergan, Genentech, and Roche. Show Less Read more